We are live on ! Find out more
KAM

Kazazian Asset Management Portfolio holdings

AUM $91.5M
1-Year Est. Return 35.36%
This Fund
S&P 500
This Quarter Est. Return
+2.51%
1 Year Est. Return
+35.36%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$107M
AUM Growth
-$2.31M
Cap. Flow
-$3.95M
Cap. Flow %
-3.69%
Top 10 Hldgs %
50.35%
Holding
99
New
11
Increased
15
Reduced
18
Closed
5

Top Buys

Rank Stock Value
1
DBRG icon
DigitalBridge
DBRG
+$1.53M
2
CLVS
Clovis Oncology, Inc.
CLVS
+$1.3M
3
PZZA icon
Papa John's
PZZA
+$1.27M
4
BIDU icon
Baidu
BIDU
+$893K
5
MLPA icon
Global X MLP ETF
MLPA
+$776K

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$6.33M
2
BIIB icon
Biogen
BIIB
+$3.41M
3
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$612K
4
RARE icon
Ultragenyx Pharmaceutical
RARE
+$482K
5
NS
NuStar Energy L.P.
NS
+$450K

Sector Composition

Rank Sector Weight
1 Healthcare 31.8%
2 Financials 12.85%
3 Consumer Discretionary 11.11%
4 Communication Services 8.2%
5 Technology 5.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EWG icon
26
iShares MSCI Germany ETF
EWG
$1.62B
$1.08M 1.01%
36,425
-12,915
-26% -$392K
V icon
27
Visa
V
$677B
$1.05M 0.98%
7,000
– –
SLV icon
28
iShares Silver Trust
SLV
$30.7B
$1.01M 0.95%
73,735
-20,545
-22% -$290K
EIGI
29
DELISTED
Endurance International Group Holdings, Inc.
EIGI
$967K 0.91%
109,908
– –
BLUE
30
DELISTED
bluebird bio
BLUE
$915K 0.86%
484
+145
+43% +$300K
IBB icon
31
iShares Biotechnology ETF
IBB
$9.77B
$915K 0.86%
7,500
– –
AERI
32
DELISTED
Aerie Pharmaceuticals
AERI
$894K 0.84%
14,517
-3,133
-18% -$201K
MRK icon
33
Merck
MRK
$318B
$820K 0.77%
12,114
– –
TRGP icon
34
Targa Resources
TRGP
$55.1B
$785K 0.74%
13,944
– –
ORCL icon
35
Oracle
ORCL
$423B
$759K 0.71%
14,716
-2,500
-15% -$121K
GWPH
36
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$757K 0.71%
4,385
+626
+17% +$90.3K
ABT icon
37
Abbott
ABT
$187B
$707K 0.66%
9,640
– –
PBYI icon
38
Puma Biotechnology
PBYI
$454M
$689K 0.65%
15,035
+6,264
+71% +$302K
SPPI
39
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$632K 0.59%
37,590
– –
ZGNX
40
DELISTED
Zogenix, Inc.
ZGNX
$622K 0.58%
12,531
-3,133
-20% -$159K
INCY icon
41
Incyte
INCY
$24.4B
$606K 0.57%
8,773
+1,253
+17% +$86K
DO
42
DELISTED
Diamond Offshore Drilling
DO
$590K 0.55%
29,480
– –
BMRN icon
43
BioMarin Pharmaceuticals
BMRN
$12.4B
$584K 0.55%
6,024
+2,890
+92% +$288K
CLLS
44
Cellectis
CLLS
$285M
$530K 0.5%
18,792
– –
NKTR icon
45
Nektar Therapeutics
NKTR
$2.58B
$524K 0.49%
573
– –
GSK icon
46
GSK
GSK
$106B
$503K 0.47%
10,024
– –
NETI
47
DELISTED
Eneti Inc.
NETI
$462K 0.43%
6,857
– –
CXO
48
DELISTED
CONCHO RESOURCES INC.
CXO
$450K 0.42%
2,949
– –
CORI
49
DELISTED
Corium International, Inc.
CORI
$417K 0.39%
43,854
– –
NBL
50
DELISTED
Noble Energy, Inc.
NBL
$401K 0.38%
12,864
– –
1
2
3 4

Similar funds

MRP
Measured Risk Portfolios San Diego, California $91.4M AUM 0.88% 1-Year Est. Return
ITG
Index Technologies Group New York $91.8M AUM
MA
Marquette Associates Chicago, Illinois $91.9M AUM 13.47% 1-Year Est. Return
AW
Aspirean Wealth Mill Valley, California $92.1M AUM
SPCM
Spruce Point Capital Management New York $90.9M AUM
ML
MLP3 LLC Linwood, New Jersey $90.7M AUM
ICM
Incision Capital Management San Francisco, California $90.6M AUM
ACMC
Anchor Capital Management Company Raleigh, North Carolina $92.7M AUM 19.36% 1-Year Est. Return

Kazazian Asset Management's Q3 2018 Portfolio in Review

As of Q3 2018, Kazazian Asset Management held 99 positions worth $107M, down 2.1% from $109M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Kazazian Asset Management withdrew a net $3.95M in Q3 2018, closing 5 positions and reducing 18 holdings. Its most notable exit was Ultragenyx Pharmaceutical, an estimated $482K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Kazazian Asset Management opened a new position in Papa John's worth $1.41M.

  • Kazazian Asset Management's largest Q3 2018 buy was Papa John's: 27,500 shares worth $1.41M.
  • Kazazian Asset Management added most to DigitalBridge in Q3 2018, an estimated $1.53M increase.
  • Kazazian Asset Management's biggest Q3 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $6.33M.
  • Kazazian Asset Management fully exited Ultragenyx Pharmaceutical in Q3 2018, selling an estimated $482K.
  • Kazazian Asset Management's ten largest holdings make up 50% of its $107M portfolio in Q3 2018.
  • Kazazian Asset Management opened 11 new positions and closed 5 in Q3 2018.
  • Kazazian Asset Management's portfolio value fell 2.1% quarter-over-quarter to $107M.

Based on Kazazian Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.